Guggenheim Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.5M | Buy |
35,351
+1,263
| +4% | +$1.28M | 0.25% | 83 |
|
|
2025
Q4 | $36.6M | Buy |
34,088
+900
| +3% | +$861K | 0.26% | 75 |
|
|
2025
Q3 | $25.3M | Buy |
33,188
+7,757
| +31% | +$5.77M | 0.18% | 108 |
|
|
2025
Q2 | $19.8M | Buy |
25,431
+1,411
| +6% | +$1.1M | 0.16% | 120 |
|
|
2025
Q1 | $19.8M | Sell |
24,020
-8,346
| -26% | -$6.94M | 0.18% | 108 |
|
|
2024
Q4 | $25M | Sell |
32,366
-4,349
| -12% | -$3.6M | 0.2% | 99 |
|
|
2024
Q3 | $32.5M | Sell |
36,715
-9,833
| -21% | -$8.84M | 0.23% | 81 |
|
|
2024
Q2 | $42.1M | Sell |
46,548
-4,491
| -9% | -$3.59M | 0.3% | 61 |
|
|
2024
Q1 | $39.7M | Sell |
51,039
-15,217
| -23% | -$10.8M | 0.28% | 68 |
|
|
2023
Q4 | $38.6M | Sell |
66,256
-10,777
| -14% | -$6.29M | 0.29% | 63 |
|
|
2023
Q3 | $41.4M | Sell |
77,033
-20,163
| -21% | -$10.4M | 0.36% | 49 |
|
|
2023
Q2 | $45.6M | Buy |
97,196
+3,915
| +4% | +$1.64M | 0.36% | 45 |
|
|
2023
Q1 | $32M | Sell |
93,281
-297
| -0.3% | -$100K | 0.27% | 70 |
|
|
2022
Q4 | $34.2M | Sell |
93,578
-25,312
| -21% | -$8.97M | 0.3% | 68 |
|
|
2022
Q3 | $38.4M | Sell |
118,890
-8,714
| -7% | -$2.76M | 0.35% | 48 |
|
|
2022
Q2 | $41.4M | Sell |
127,604
-25,960
| -17% | -$7.79M | 0.33% | 52 |
|
|
2022
Q1 | $44M | Sell |
153,564
-8,293
| -5% | -$2.13M | 0.26% | 63 |
|
|
2021
Q4 | $44.7M | Buy |
161,857
+8,252
| +5% | +$2.09M | 0.23% | 78 |
|
|
2021
Q3 | $35.5M | Buy |
153,605
+33,882
| +28% | +$8.36M | 0.21% | 81 |
|
|
2021
Q2 | $27.5M | Sell |
119,723
-3,606
| -3% | -$724K | 0.16% | 118 |
|
|
2021
Q1 | $23M | Sell |
123,329
-4,046
| -3% | -$791K | 0.15% | 139 |
|
|
2020
Q4 | $21.5M | Buy |
127,375
+23,814
| +23% | +$3.56M | 0.13% | 125 |
|
|
2020
Q3 | $15.3M | Sell |
103,561
-22,353
| -18% | -$3.46M | 0.11% | 168 |
|
|
2020
Q2 | $20.7M | Buy |
125,914
+22,597
| +22% | +$3.47M | 0.16% | 116 |
|
|
2020
Q1 | $14.3M | Sell |
103,317
-82,154
| -44% | -$11.3M | 0.14% | 139 |
|
|
2019
Q4 | $24.4M | Buy |
185,471
+35,150
| +23% | +$4.07M | 0.18% | 113 |
|
|
2019
Q3 | $16.8M | Buy |
150,321
+21,965
| +17% | +$2.45M | 0.13% | 172 |
|
|
2019
Q2 | $14.2M | Sell |
128,356
-9,198
| -7% | -$1.08M | 0.12% | 191 |
|
|
2019
Q1 | $17.9M | Sell |
137,554
-13,195
| -9% | -$1.6M | 0.15% | 134 |
|
|
2018
Q4 | $17.4M | Sell |
150,749
-22,489
| -13% | -$2.51M | 0.15% | 131 |
|
|
2018
Q3 | $18.6M | Buy |
173,238
+18,953
| +12% | +$1.89M | 0.12% | 160 |
|
|
2018
Q2 | $13.2M | Sell |
154,285
-535,834
| -78% | -$44M | 0.09% | 248 |
|
|
2018
Q1 | $53.4M | Sell |
690,119
-11,780
| -2% | -$948K | 0.13% | 259 |
|
|
2017
Q4 | $59.3M | Buy |
701,899
+124,217
| +22% | +$10.6M | 0.14% | 230 |
|
|
2017
Q3 | $49.4M | Sell |
577,682
-52,067
| -8% | -$4.27M | 0.12% | 309 |
|
|
2017
Q2 | $51.8M | Buy |
629,749
+73,997
| +13% | +$6.04M | 0.14% | 261 |
|
|
2017
Q1 | $46.7M | Sell |
555,752
-60,179
| -10% | -$4.82M | 0.13% | 320 |
|
|
2016
Q4 | $45.3M | Buy |
615,931
+106,431
| +21% | +$7.93M | 0.13% | 281 |
|
|
2016
Q3 | $40.9M | Sell |
509,500
-109,821
| -18% | -$8.79M | 0.13% | 271 |
|
|
2016
Q2 | $48.8M | Buy |
619,321
+52,264
| +9% | +$3.93M | 0.15% | 177 |
|
|
2016
Q1 | $40.8M | Sell |
567,057
-4,713
| -0.8% | -$357K | 0.13% | 243 |
|
|
2015
Q4 | $48.2M | Sell |
571,770
-49,058
| -8% | -$4.07M | 0.14% | 198 |
|
|
2015
Q3 | $52M | Sell |
620,828
-268,495
| -30% | -$22.7M | 0.16% | 132 |
|
|
2015
Q2 | $74.2M | Sell |
889,323
-177,332
| -17% | -$13.5M | 0.18% | 86 |
|
|
2015
Q1 | $77.5M | Buy |
1,066,655
+122,843
| +13% | +$8.75M | 0.18% | 92 |
|
|
2014
Q4 | $65.1M | Sell |
943,812
-97,894
| -9% | -$6.61M | 0.16% | 129 |
|
|
2014
Q3 | $67.6M | Sell |
1,041,706
-20,462
| -2% | -$1.3M | 0.16% | 105 |
|
|
2014
Q2 | $66M | Sell |
1,062,168
-155,190
| -13% | -$9.26M | 0.17% | 109 |
|
|
2014
Q1 | $71.7M | Buy |
1,217,358
+161,122
| +15% | +$8.99M | 0.2% | 69 |
|
|
2013
Q4 | $53.9M | Buy |
1,056,236
+1,832
| +0.2% | +$91.7K | 0.16% | 113 |
|
|
2013
Q3 | $53.1M | Buy |
1,054,404
+239,250
| +29% | +$12.5M | 0.19% | 73 |
|
|
2013
Q2 | $40M | Buy |
+815,154
| New | +$44.4M | 0.17% | 91 |
|
Other funds holding LLY
VCM
VPM
Guggenheim Capital's LLY Position: Q1 2026 in Review
Guggenheim Capital increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $1.28M and bringing the position to 35,351 shares worth $32.5M. The position accounts for 0.25% of the portfolio, ranked #83.
Guggenheim Capital first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.5M in Q1 2015. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Guggenheim Capital held 35,351 shares of Eli Lilly worth $32.5M as of Q1 2026.
- Guggenheim Capital bought 1,263 Eli Lilly shares in Q1 2026, an estimated $1.28M.
- Eli Lilly made up 0.25% of Guggenheim Capital's portfolio in Q1 2026, its #83 holding.
- Guggenheim Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Eli Lilly position peaked at $77.5M in Q1 2015.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.